Cytek Biosciences, Inc. (CTKB)
NASDAQ · Healthcare
Cytek Biosciences, Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 201.5M | 200.5M | 193.0M | 164.0M | 128.0M | 92.8M |
| Gross Profit | 104.5M | 111.1M | 109.4M | 101.0M | 79.1M | 51.7M |
| Profitability | ||||||
| Operating Income | -40.4M | -20.5M | -27.8M | -1.8M | 9.2M | 13.7M |
| EBITDA | -32.8M | -13.3M | -21.8M | 688,000 | 10.4M | 14.3M |
| Net Income | -66.5M | -6.0M | -12.1M | 2.5M | 3.0M | 19.4M |
| Per Share Data | ||||||
| EPS (diluted) | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 128M | 131M | 135M | 139M | 82M | 33M |
Cytek Biosciences, Inc. Income Statement — FAQ
Cytek Biosciences, Inc. (CTKB) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTKB's income statement history?
The chart and table above show Cytek Biosciences, Inc.'s income statement by year and by quarter, including the growth rate.